Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC

Clinical trial NCT04446117 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04446117
Sponsor: Exelixis
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Prostate Adenocarcinoma

Start date: 2020-10-19
Primary completion: 2024-04-19
Enrollment: 575

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.